{
    "title": "GlaxoSmithKline spinoff Haleon raises growth forecast by up to 8% as it benefits from demand for cold and flu treatments",
    "url": "https://www.dailymail.co.uk/money/markets/article-11055051/GlaxoSmithKline-spinoff-Haleon-raises-growth-forecast-8.html",
    "date": "2022-07-27",
    "keywords": [
        "growth",
        "share",
        "fund",
        "glaxosmithkline",
        "spinoff",
        "demand",
        "money",
        "investment",
        "account",
        "fee",
        "haleon",
        "bounceback",
        "flu",
        "owner",
        "centrum",
        "toothpaste",
        "end",
        "june",
        "period",
        "year",
        "winter",
        "omicron",
        "variant",
        "covid",
        "theraflu",
        "pain",
        "relief",
        "supplement",
        "price",
        "europe",
        "inflation",
        "business",
        "exit",
        "rio",
        "tinto",
        "trading",
        "precovid",
        "pub",
        "tobacco",
        "wizz",
        "air",
        "budget",
        "airline",
        "london",
        "car",
        "virgin",
        "easyaccess",
        "article",
        "capital",
        "risk",
        "isa",
        "trade",
        "month",
        "community",
        "model",
        "affiliate",
        "product",
        "commission",
        "editorial",
        "independence",
        "investing",
        "platform"
    ],
    "category": [
        "money",
        "markets"
    ]
}